Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/2, Open-Label, Nonrandomized, Multi-arm Umbrella Study of Biomarker-Selected Dual-Target CAR-T Cell Modules in Adults With Relapsed or Refractory Hematologic Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07523555
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:56.923656+00:00
Published At
2026-04-13T00:00:00+00:00
Record Updated At
2026-04-13
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia", "Relapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLL", "Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia", "Relapsed/Refractory Acute Myeloid Leukemia, High-risk Myelodysplastic Neoplasm", "BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia", "T-lymphoblastic Lymphoma", "Peripheral T-cell Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-13"
protocolSection.identificationModule.nctId
"NCT07523555"
protocolSection.identificationModule.officialTitle
"A Phase 1/2, Open-Label, Nonrandomized, Multi-arm Umbrella Study of Biomarker-Selected Dual-Target CAR-T Cell Modules in Adults With Relapsed or Refractory Hematologic Malignancies"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Relapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLL (protocolSection.conditionsModule.conditions)
  • Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia (protocolSection.conditionsModule.conditions)
  • Relapsed/Refractory Acute Myeloid Leukemia, High-risk Myelodysplastic Neoplasm (protocolSection.conditionsModule.conditions)
  • BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • T-lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Peripheral T-cell Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.